Anchor Investors Confirmed
Comparable: ARM Holdings IPO (September 2023)
ARM Holdings — also a chip-IP company with concentrated customers — IPO'd at $51/share via Morgan Stanley (same lead underwriter as CBRS). ARM opened at $56.10 (+10% day one), reached $69 at peak, and has since traded between $60–$190. The ARM IPO is the most relevant comparable for Cerebras: premium AI chip story, Morgan Stanley lead, strong institutional demand, concentrated customer base.
CBRS First-Day Open Target: $175–$200
The book has been raised twice and is 20x+ oversubscribed. At the new midpoint of $155, a 13–29% first-day pop would put CBRS opening at $175–$200. ARM Holdings (same lead underwriter — Morgan Stanley) popped 25% on day one from $51 → $63. With demand substantially stronger than ARM's roadshow, the bull case is a $190–$200+ opening print. Base case given the elevated starting price: $165–$180 (+6–16% from $155 midpoint). The twice-raised price range partially captures demand — buyers already priced in most of the pop at the offer level.
Bear Case: What Could Suppress the Pop
If any of the following hits before May 14 open: (1) OpenAI announces a competing chip supplier, (2) Abu Dhabi / G42 national security action, (3) Broader Nasdaq selloff, (4) Negative CBRS-specific news in financial press. In these scenarios, CBRS could open near the offer price ($150–$160), with underwriters exercising stabilization bids to support the floor. Note: with the stock already priced at a 43% premium to last private round and 65x trailing revenue, any macro or company-specific risk is amplified.
Have a funded brokerage account ready before May 14
Any standard U.S. brokerage works: Robinhood, Fidelity, Schwab, TD Ameritrade, E*TRADE, Webull, Public.com, or Interactive Brokers. Your account must be funded — don't wait for transfers to clear on IPO day itself.
Search ticker "CBRS" on Nasdaq
On your brokerage's search bar, enter CBRS. Confirm it shows "Nasdaq Global Select Market" and "Cerebras Systems" before placing any order. Double-check — some brokerages pre-populate similar tickers.
Place a limit order — not a market order
IPO first-day trading is volatile. A market order executes at whatever price the stock is trading when your order hits — which could be 20–40% above the offer price in the first few minutes. A limit order lets you set the maximum price you'll pay. Set it at the price you actually want to pay, not at the current quote.
Wait for the first trade print (~30–90 min after market open)
Nasdaq market officially opens at 9:30 AM ET, but the first CBRS trade often prints 30–90 minutes later while underwriters balance the order book. Don't panic if CBRS doesn't show a price immediately — this is normal for high-demand IPOs.
(Optional) Request IPO allocation — Robinhood likely; SoFi/Public unconfirmed
Retail IPO allocation confirmed access: Robinhood IPO Access (most likely to carry CBRS), Fidelity, Schwab, E*TRADE. Unconfirmed for CBRS at time of writing: SoFi Invest, Public.com. If your brokerage offers IPO access, you can request allocation to buy at the final offer price (within $150–$160) before market open — the request window closes at pricing (May 13). Allocation is pro-rated and not guaranteed. At 20x+ oversubscribed, retail allocation is likely very small.
| Bank | Role | Notable |
|---|---|---|
| Morgan Stanley | Lead Book-Runner | Also led Arm Holdings IPO (2023, largest in 2 years) |
| Citigroup | Book-Runner | Major institutional distribution |
| Barclays | Book-Runner | European institutional access |
| UBS | Book-Runner | Global wealth management distribution |
| Wells Fargo | Book-Runner | U.S. institutional and retail distribution |
| Evercore ISI | Co-Manager | Independent advisory strength |
| Piper Sandler | Co-Manager | Tech-focused research coverage |
| Stifel | Co-Manager | Mid-market institutional |
| William Blair | Co-Manager | Growth equity specialization |
Morgan Stanley as lead is a signal of institutional confidence — the same bank ran the Arm Holdings IPO in September 2023, the largest U.S. tech IPO in two years at the time.
📈 Bullish signals
- CBRS opens more than 15% above midpoint ($178+) — confirms institutional demand wasn't exhausted at raised range
- High volume in first 30 minutes without sharp giveback
- Morgan Stanley stabilization bid visible (price holds offer floor on any dip)
- OpenAI or AWS mentions of Cerebras partnership on IPO day
- Revenue multiple expansion if AI chip sector rallies into the open
📉 Watch out for
- Opening price below $155 new offer midpoint — indicates demand exhausted at raised range
- Abu Dhabi / G42 concentration mentioned in morning news cycle
- Any Nvidia data or guidance that suggests GPU market share gain
- OpenAI announcing a new compute supplier other than Cerebras
- High opening pop followed by immediate reversal — "flipping" by institutional allocatees
📊 Key technical levels
- $150 — low end of raised offer range (underwriter stabilization floor)
- $155 — IPO midpoint; closes below this is weak
- $160 — high end of raised offer range; important psychological level
- $178+ — 15% IPO pop from midpoint (strong demand signal)
- Volume: watch vs. the 30M share offering size as reference for day's float
⏱️ IPO day timeline
- Night of May 13: Final IPO price announced (usually 6–9 PM ET)
- 9:30 AM ET May 14: Nasdaq market opens
- 9:30–11:00 AM: First CBRS trade prints (typical delay range)
- ~11 AM–1 PM: Price discovery period — highest volatility window
- 3:30–4:00 PM: Close — day-one settlement price established
- 30 days post-IPO: Underwriter overallotment (greenshoe) option expires
Customer concentration — OpenAI is majority of revenue
OpenAI's $20B+ multi-year deal is the primary revenue driver. If that relationship deteriorates, contracts are renegotiated, or OpenAI pivots to a competing chip supplier, Cerebras' revenue base collapses. The S-1 discloses this explicitly as a material risk. Cerebras is simultaneously OpenAI's chip supplier and competing with OpenAI's own o3/o4 inference business.
Abu Dhabi / G42 concentration (~86% compute utilization)
G42, a sovereign-backed entity from Abu Dhabi, accounts for approximately 86% of Cerebras' compute capacity utilization. This creates national security scrutiny risk — CFIUS has reviewed U.S. AI chip transfers to UAE-linked entities. Any regulatory action or export control tightening could materially impact revenue.
Premium valuation: ~65x trailing vs Nvidia 30x forward
At the $155 midpoint, CBRS trades at approximately 65x 2025 revenue ($510M). Nvidia trades at ~30x forward revenue. Cerebras is priced for perfection at the twice-raised IPO range — the stock already reflects a 43% premium to the last private round. Any revenue miss, guidance cut, or sector multiple compression would disproportionately impact CBRS at this premium. The higher the IPO price, the less margin for error.
US-billed revenue DECLINED 34% YoY ($282.7M → $187.6M)
Despite total revenue growing 76%, Cerebras' US-domestic business actually shrank 34% year-over-year. All growth came from international (Abu Dhabi) bookings. This structural divergence means Cerebras' US customer base is contracting, not expanding — making the company more dependent on Abu Dhabi concentration and the OpenAI deal than headline revenue growth implies.
Nvidia competition and GPU ecosystem dominance
Nvidia's CUDA ecosystem has 12+ years of software lock-in. Cerebras' wafer-scale architecture requires different tooling and workflow changes for customers. Enterprise AI budgets are dominated by Nvidia-certified workloads. Cerebras competes on inference speed but faces software ecosystem headwinds that take years to overcome.
Lock-up expiration (typically 180 days post-IPO)
Employee and early investor shares are typically locked up for 180 days post-IPO — approximately November 2026. At lockup expiration, significant selling pressure can emerge. Cerebras insiders hold substantial equity at the IPO valuation. Watch the 6-month mark post-listing.
TechStackIPO may earn a commission on brokerage referrals. This is not investment advice. Past IPO performance does not predict future results.
📅 30-Day Window (May 14 – June 13)
- Greenshoe exercise: If CBRS trades above offer price, Morgan Stanley will exercise the 4.2M share overallotment within 30 days — a bullish signal that demand was real
- Lock-up cliffs: No early lock-up expiry expected in 30-day window; insiders locked for 180 days
- Volume trend: High volume sustaining into week 2 = institutional conviction. Volume collapse = flippers exiting
- OpenAI news: Any OpenAI GPU/compute update that impacts Cerebras deal terms will move the stock
📊 Q2 2026 Earnings (August 2026)
- US-billed revenue: Watch if domestic revenue decline reverses; it fell 34% in 2025 ($282.7M → $187.6M)
- Customer diversification: Any new non-OpenAI, non-UAE customer of meaningful size changes the concentration narrative
- AWS revenue recognition: The binding term sheet should convert to contracts — watch for AWS revenue contribution in first public earnings
- Non-GAAP operating loss: GAAP net income is $87.9M but non-GAAP operating loss was $75.7M — post-IPO investors will focus on adjusted profitability trajectory
⚠️ Regulatory / Policy
- Export controls: Any new BIS rules on AI chip exports to UAE or non-allied nations could restrict G42-linked revenue
- CFIUS follow-on: G42 was removed from the cap table but remains the largest revenue customer — ongoing CFIUS monitoring possible
- UAE tech policy: Abu Dhabi / MBZUAI organizational changes could affect purchasing patterns
🔒 Lock-Up Expiry (~November 2026)
- 180-day lock-up: Standard IPO lock-up expires ~November 10, 2026 — when insiders and early investors can sell
- Insider ownership: Abu Dhabi Growth Fund, AMD, Benchmark hold substantial pre-IPO equity at much lower cost basis
- Secondary offerings: Watch for registered secondary filings in Oct–Nov 2026 window as indicator of insider intent to sell
Get CBRS Day-One Alerts via SMS & Email
Real-time IPO alerts: pricing confirmation, first trade print, day-one close price, post-IPO analysis. Delivered via SMS + email the morning it moves.
Tracks 375+ pre-IPO companies including SpaceX, OpenAI, Anthropic